Since Stellapharm was established in 2000 (formerly known as STADA-VN and re-branded since 19 August 2019), we are now one of Vietnam leading generics manufacturers. Stellapharm’s Products are now in use by millions of patients across more than 50 countries worldwide.

At Stellapharm, we create quality through ethical professionalism, devotion to quality and technology meanwhile safeguarding all environmental values. Stellapharm is globally recognized for its quality through accreditation from EMA, PMDA, WHO , TFDA, etc.

We always commit ourselves to providing high quality medicines with affordable price to our patients across the world.

  • 931+

    931+ Employees

  • 02+

    02 Factories

  • 200+

    200+ Products

  • 50+

    Exporting to 50+ Countries


To be the biggest local company in pharmaceutical and healthcare products with active presence on not less than 50 overseas markets by 2025.

To become an active, trustworthy international player in the pharmaceutical sector by 2030.


To be a manufacturer of high-quality medicines and healthcare products at affordable prices through international technical partnership, facilitating access to new medicines, especially those for chronic diseases.

To create customers for life.


Understanding the need of community for an affordable healthy life and its improvement, we are exerting all the efforts to keep our quality, product portfolio and service updated, fine-tuned, striking the best balance between the costs versus the benefits of our customers. Maintaining respectful relations with customers, partners, suppliers, and communities.


“Together we can”

Stellapharm believes in fostering an inclusive professional environment where each employee knows he/she can achieve a solid future as well as a good personality and professionalism; perceives workplace as their home while working and making meaningful contributions. Our presence does not just come from what we do. It’s how we do things and why that really matters. We appreciate every exertion and dedication that each employee contributes not only for a development of company but also for an improvement in community healthcare. It spreads inspiration internally, increases the strength of union to fulfill our vision and mission. Moreover, we understand the relationship connection between each member in Stellapharm’s family is one of the most important keys of our culture.

Advisory Board

As Stellapharm’s leaders, our responsibility is to inspire and engage our team and employees to achieve a unique motto “quality at affordable price” and bring our company growth and business.

Management Board


The company was established in 2000 in Ho Chi Minh City, a biggest and busiest with energy in Vietnam, under the name M.S.T Pharma. At that time, the company’s representatives recognized that the industrial manufacture of generics drugs would be an advance in the protection of people health.

The first private pharmaceutical factory in Vietnam was built in Hoc Mon, Ho Chi Minh City focusing on tablets, and ointments and accredited with ASEAN GMP for its production facility

By seeing the growth market of pharmaceutical sector, the Company’s Representatives decided to expand its business, product portfolio and established STADA-Vietnam Joint Venture Company with its partner from Germany, the STADA Arzneimittel marked as first joint venture in pharmaceutical sector in Vietnam.

A new milestone was reached by successfully conducting bioequivalence of Lamzidivir product and launching the Duo ARV Lamzidivir giving us the first local manufacturer of generic ARVs in Vietnam and ASEAN.

After 5 years operation, the production capacity of first factory was almost reached its design. The top management decided to expand its business by investing to new European Standard facility in Binh Duong, Vietnam, allowing the company to export products to Europe and Asia Countries.

The second facility has become first factory in Vietnam accredited EU-GMP by Federal Ministry of Health (Germany) and WHO-GMP by the Ministry of Health of Vietnam.

The top management and their partners celebrated the grand opening ceremony for the EU-GMP facility on Jan 2008 and become as a first company exporting Paracetamol product to European markets; The Research and Development Unit located in Binh Duong was aslo certified with ISO 9001:2008. At the same time, the first factory granted with WHO-GMP after its upgradation.

We proud of our Binh Duong facility accredited with International WHO by Geneva World Health Organization affirming our commitment to high quality products to patients worldwide.

The company reached the new milestone by complying with Japan GMP by PMDA, one of the most developed pharmaceutical country in the world.

On closing its year, the sale turnover reached 100 million $, exceeding the target set on 2020, saying that until now, the product capacity reaches more than 2.8 billion units per year with over 200 products reached millions of patients in over 50 number of markets around the world.

After a period of time, the company has signed Sub-Licensing Agreement with Hetero and Gilead allowing the company to manufacture Hepatitis C Product. This was a breakthrough line for the company in strengthening our portfolio and commitment to people’s healthcare.

The Company was completed successfully the 5th EU-GMP Inspection at Binh Duong manufacturing site by the inspector from Regierungspräsidium Darmstadt (EMA) on 7 March 2019. This 5th EU Accreditation allows us to ensure our quality commitment to millions of patients across the world that we have maintained since 2007. Lesovir, a fixed dose combination product (Hepatitis C), was launched to the local market on May 2019 that helping the low- and mid- income patients in Vietnam to access the treatment. Due to our strategic development, the Company rebranded the company name to new brand “STELLA” on 16 August 2019 approved by Department of Planning and Investment, HCMC.